| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/15/1996 | WO1996004300A1 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection |
| 02/15/1996 | WO1996004011A2 Novel compound to mimic a naturally occurring peptide's effect |
| 02/15/1996 | WO1996004010A1 Vr-2332 viral nucleotide sequence and methods of use |
| 02/15/1996 | WO1996004009A1 Anti-aids secretory recombinant bcg vaccine |
| 02/15/1996 | WO1996004006A1 USE OF AT LEAST ONE FORM OF THE β2-GLYCOPROTEIN I AS AN ANTI-INFECTIOUS AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
| 02/15/1996 | WO1996004005A1 Pharmaceutical compositions containing extracted mhc molecules, for stimulation of the immune system |
| 02/15/1996 | WO1996004004A1 Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular diseases |
| 02/15/1996 | WO1996004002A1 Remedy for corneal diseases |
| 02/15/1996 | WO1996004000A1 PEPTIDE-BASED NUCLEIC ACID MIMICS (PENAMs) |
| 02/15/1996 | WO1996003883A1 Cells bearing cd4 decoy receptors and related molecules and methods |
| 02/15/1996 | WO1996002645A3 Htk ligand |
| 02/15/1996 | WO1996000586A3 Methods for treating cell proliferative disorders by modulating signal transduction |
| 02/15/1996 | WO1996000083A3 Method of isolating an antigene preparation |
| 02/15/1996 | WO1995034650A3 Mn gene and protein |
| 02/15/1996 | WO1995032285A3 Transgenic arthritic mice |
| 02/15/1996 | WO1995026982A3 Malaria peptides |
| 02/15/1996 | WO1995021250A3 Production of pharmaceutical-grade plasmid dna |
| 02/15/1996 | DE4428402A1 Gentherapeutisches Verfahren unter Verwendung von DNA-Vektoren ohne Selektionsmarker-Gen Gene therapy methods using DNA vectors without selectable marker gene |
| 02/15/1996 | DE3891231C2 Astigmatism correcting laser surgical set |
| 02/15/1996 | CA2328638A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | CA2196687A1 Corneal therapeutic agent |
| 02/15/1996 | CA2196569A1 Aspb1 insulin analogs |
| 02/15/1996 | CA2196290A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | CA2196285A1 Contraceptive vaccine |
| 02/15/1996 | CA2196200A1 Novel compounds |
| 02/15/1996 | CA2196195A1 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection |
| 02/15/1996 | CA2196190A1 Ikaros transgenic cells and animals |
| 02/15/1996 | CA2195672A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 02/15/1996 | CA2195312A1 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| 02/15/1996 | CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/14/1996 | EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus |
| 02/14/1996 | EP0696596A1 Detection, assay and isolation of compounds having the taxane ring skeleton |
| 02/14/1996 | EP0696595A1 Low temperature albumin fractionation using sodium caprylate as a partitioning agent |
| 02/14/1996 | EP0696594A1 Human interleukin 6 inhibitor |
| 02/14/1996 | EP0696593A2 Inhibitors of farnesyl protein transferase |
| 02/14/1996 | EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels |
| 02/14/1996 | EP0696427A1 Method for producing milk fraction having high emulsifying strength and product using the fraction |
| 02/14/1996 | EP0696325A1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c |
| 02/14/1996 | EP0696324A1 Integrative dna segment comprising gene encoding insecticidal protein |
| 02/14/1996 | EP0696323A1 Recombinant alanine racemase and gapdh from tolypocladium |
| 02/14/1996 | EP0696322A1 METHODS AND COMPOSITIONS FOR $i(SALMONELLA)-BASED VACCINES |
| 02/14/1996 | EP0696321A1 Macrophage inflammatory protein variants |
| 02/14/1996 | EP0696320A1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 02/14/1996 | EP0696318A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 02/14/1996 | EP0696290A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
| 02/14/1996 | EP0696206A1 Adenoviruses having modified fiber proteins |
| 02/14/1996 | EP0696204A1 Recombinant fowlpox viruses and uses thereof |
| 02/14/1996 | EP0696203A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis |
| 02/14/1996 | EP0696200A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 02/14/1996 | EP0696198A1 Novel polypeptide having factor xa inhibitory activity |
| 02/14/1996 | EP0205579B1 Methods and compositions useful in the diagnosis and treatment of autoimmune diseases |
| 02/14/1996 | CN1116629A Monomeric insulin analog formulations |
| 02/14/1996 | CN1116628A Cyclopeptides of the formulal |
| 02/14/1996 | CN1030999C Process for preparation of trypsin inhibitor |
| 02/14/1996 | CN1030988C Crystalline huma proinsulin and process for its production |
| 02/13/1996 | US5491288 Chimeric gene comprising the arabidopsis histone H4 promoter for the transformation of plants |
| 02/13/1996 | US5491285 Phytophthora resistance gene of catharanthus and its use |
| 02/13/1996 | US5491283 Transgene expressed in bone marrow cells; effective in promoting leukemia |
| 02/13/1996 | US5491225 PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
| 02/13/1996 | US5491220 Surface loop structural analogues of fibroblast growth factors |
| 02/13/1996 | US5491219 Magnetic responsiveness |
| 02/13/1996 | US5491216 Tri-arginine insulins |
| 02/13/1996 | US5491132 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
| 02/13/1996 | US5491130 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 02/13/1996 | US5491129 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 02/13/1996 | US5491128 Aglycons of A/16686 antibiotics |
| 02/13/1996 | US5491088 Genetic engineering |
| 02/13/1996 | US5491084 Possesses regulatory element from a gene; culturing cells permitting expression of protein |
| 02/13/1996 | US5491081 Genetic engineering; introgressing soybean cyst nematode resistance into elite soybean germplasm using nucleic acid marker |
| 02/13/1996 | US5491074 Joining peptides by attaching association hexapeptide to each, mixing fusion complexes formed to dimerize association peptide |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/13/1996 | US5491065 Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF |
| 02/13/1996 | US5491064 Purified nucleic acid having sequence complementary to and binding specifically to given dna sequence |
| 02/13/1996 | US5491062 Polynucleotide amplification mycoplasma assay, primers, and kits therefore |
| 02/13/1996 | US5490981 Diagnostic and therapeutic compositions and methods for lipoprotein(a) |
| 02/12/1996 | CA2155448A1 Inhibitors of farnesyl protein transferase |
| 02/11/1996 | CA2155629A1 Human interleukin 6 inhibitor |
| 02/09/1996 | CA2155496A1 Nucleic acid-binding oligomers for therapy and diagnosis |
| 02/08/1996 | WO1996003653A1 Superparamagnetic particles, process for their production and their use |
| 02/08/1996 | WO1996003652A1 Determination of a specific immunoglobulin using multiple antigens |
| 02/08/1996 | WO1996003651A1 Peptides marked with metal chelates |
| 02/08/1996 | WO1996003650A1 Oligomer carrier molecules in which marker groups and haptens are selectively incorporated |
| 02/08/1996 | WO1996003649A1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
| 02/08/1996 | WO1996003527A2 Diagnostic method and probe |
| 02/08/1996 | WO1996003522A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003519A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003517A1 Process for preparing viruses and viral vectors |
| 02/08/1996 | WO1996003515A2 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | WO1996003514A1 Picornavirus l proteinase and methods of making and using thereof |
| 02/08/1996 | WO1996003510A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | WO1996003509A2 Insect viruses, sequences, insecticidal compositions and methods of use |
| 02/08/1996 | WO1996003508A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 02/08/1996 | WO1996003507A1 Method of isolating attenuated virus and vaccine thereof |
| 02/08/1996 | WO1996003506A2 Analog of haemophilus hin47 with reduced protease activity |
| 02/08/1996 | WO1996003505A1 HARD AND SOFT WHEAT THIOREDOXINS h, HOMOLOGOUS PROTEINS, DNA FRAGMENTS CODING FOR SAID PROTEINS AND METHODS FOR PREPARING SAME |
| 02/08/1996 | WO1996003504A1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 02/08/1996 | WO1996003503A1 Process for producing urinary trypsin inhibitor and domains thereof, novel polypeptide related to the both, and process for producing the polypeptide |
| 02/08/1996 | WO1996003502A2 Muc1 derived proteins for the diagnosis, imaging and therapy of human cancer |
| 02/08/1996 | WO1996003499A1 Receptor-ligand assay |